UNSPSC 85471926: Bypass cerebral ventricle to intestine with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass cerebral ventricle to intestine with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 00163K5

UNSPSC 85471926 Bypass cerebral ventricle to intestine with nonautologous tissue substitute, percutaneous approach is a Commodity code that shows no relevant recent activity in state and local procurement. The code describes a specific neurosurgical implant procedure, yet the recent opportunities posted under it involve occupational medical surveillance, independent medical evaluations for disability determinations, pharmacy benefit management, surgical carve-out networks, temporary health professional staffing, and youth detention medical services — none of which relate to cerebral ventricle bypass procedures or implantable medical devices. This mismatch suggests the code has been misapplied to general healthcare administration and staffing solicitations rather than to the specialized surgical product or procedure it nominally describes.

State and local procurement bodies do not appear to be sourcing this specific procedure or device type through open solicitation channels at present. The recent opportunities span Arizona (Phoenix Retirement Office), California (City of Long Beach, Collier County, Santa Clara County Health System), Washington (Department of Transportation), and Texas (Harris County), but none address cerebral ventricle bypass procedures, neurosurgical implants, or related procurement. Business development professionals should monitor whether the code is recalibrated in future solicitation databases or whether genuine neurosurgical procurement activity emerges under corrected coding; currently, no actionable market signal exists under this code for firms in the implantable medical device or neurosurgical services space.